Thirteen years of culture-positive M. bovis-BCG infection in an IL-12Rβ1 deficient patient: Treatment and outcome

Journal of Infection

Volumn 52, Issue 3, 2006, Pages

  Rosenzweig, S D ^a   Yancoski, J ^a   Bernasconi, A ^a   Krasovec, S ^a   Marciano, B E ^a   Casimir, L ^a   Berberian, G ^a   Simboli N ^b   Rousseau, M ^a   Calle, G ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Anti mycobacterial treatment; Interferon ; Multidrug resistant Mycobacterium bovis BCG

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; BCG VACCINE; CAPREOMYCIN; CLOFAZIMINE; ETHAMBUTOL; ETHIONAMIDE; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12 RECEPTOR BETA1; ISONIAZID; KANAMYCIN; LINEZOLID; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RECOMBINANT GAMMA INTERFERON; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CASE REPORT; CLINICAL PROTOCOL; DRUG WITHDRAWAL; FLOW CYTOMETRY; GENETIC POLYMORPHISM; HUMAN; INTESTINE ABSORPTION; LUNG INFECTION; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM BOVIS; NONHUMAN; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; STOP CODON; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MYCOBACTERIUM BOVIS; RECEPTORS, INTERLEUKIN-12; TUBERCULOSIS;

EID: 33344473484     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.07.009     Document Type: Article

References (9)

1. S.D. Rosenzweig S.M. Holland Congenital defects in the in the interferon-gamma/interleukin-12 pathway Curr Opin Pediatr 16 2004 3-8
2. J.-L. Casanova L. Abel Genetic dissection of immunity against mycobacteria: The human model Annu Rev Immunol 20 2002 581-620
3. S.E. Dorman C. Picard D. Lammas K Heyne JT van Dissel R Baretto et. al. Clinical features of dominant and recessive interferon-γ receptor 1 deficiencies Lancet 364 2004 2113-2121
4. C. Fieschi S. Dupuis E. Catherinot J Feinberg J Bustamente A Breiman et. al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor: Medical and immunological implications J Exp Med 197 2003 527-535
5. A.A. Akhiani J. Pappo Z. Kabok K Schon W Gao LE Franzen et. al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells J Immunol 169 2002 6977-6984
6. J. Bauditz M. Ortner M. Bierbaum G Niedobitek H Lochs S Schreiber et. al. Production of IL-12 in gastritis relates to infection with Helicobacter pylori Clin Exp Immunol 117 1999 316-323
7. F. Meyer K.T. Wilson S.P. James Modulation of innate cytokine response by products of Helicobacter pylori Infect Immun 68 2000 6265-6272
8. N. Sawai M. Kita T. Kodama T Tanahashi Y Yamaoka Y Tagawa et. al. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model Infect Immun 67 1999 279-285
9. A.M. Bressler S.M. Zimmer J.L. Gilmore J Somani Peripheral neuropathy associated with prolonged use of linezolid Lancet Infect Dis 4 2004 528-531